SCHEMBL20646153

SCHEMBL20646153

C[Si](C)(C)O[Si](C)(C)CCCCCCCCCc1ccc(-c2ccc(C#N)nc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
PDE10A Q9Y233 1/20 0.35
MCHR1 Q99705 1/20 0.35
NAAA Q02083 1/20 0.34
CHEK1 O14757 5/20 0.34
MAPT P10636 3/20 0.33
RAB9A P51151 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CTSC P53634 2/20 0.32
ACHE P22303 2/20 0.32
SCN10A Q9Y5Y9 1/20 0.32
FAAH O00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20646109 0.86 KDM4E (0.43) PDE10AMCHR1CHEK1KDM4EALDH1A1
SCHEMBL20646095 0.84 SPHK1 (0.41)
SCHEMBL20646099 0.79 L3MBTL1 (0.52) HSD17B10TSHRNAAAMAPTRAB9A
SCHEMBL20646151 0.78 TSHR (0.41) HSD17B10TSHRMAPTKDM4EMEN1
SCHEMBL16215324 0.78 TSHR (0.56) HSD17B10TSHRMAPTHPGDFAAH
SCHEMBL20646160 0.76 RAB9A (0.48) HSD17B10TSHRMAPTRAB9AKDM4E
SCHEMBL20646112 0.73 KDM4E (0.40) HSD17B10TSHRMCHR1KDM4EALDH1A1
SCHEMBL15045544 0.73 KDM4E (0.50) KDM4EALDH1A1HPGDL3MBTL1
SCHEMBL17225149 0.73 KDM4E (0.50) KDM4EALDH1A1HPGDL3MBTL1
SCHEMBL8913600 0.72 RARB (0.48) HSD17B10TSHRMAPTMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10954444-B2 Liquid crystal compound and use thereof LG CHEM, LTD. 2021-03-23 US disclosed
US-20190016956-A1 NOVEL LIQUID CRYSTAL COMPOUND AND USE THEREOF LG CHEM, LTD. (KR) 2019-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10954444-B2 Liquid crystal compound and use thereof CNOT9, SCLY, SFXN3 HSD17B10 1068/4885TSHR 4695/4885PDE10A 343/4885
US-20190016956-A1 NOVEL LIQUID CRYSTAL COMPOUND AND USE THEREOF CNOT9, SFXN3, TLK2 HSD17B10 1367/4885TSHR 4737/4885PDE10A 494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.